Adherence to varenicline among african american smokers: An exploratory analysis comparing plasma concentration, pill count, and self-report

Nicotine and Tobacco Research

Volumn 14, Issue 9, 2012, Pages 1083-1091

  Buchanan, Taneisha S ^a   Berg, Carla J ^b   Cox, Lisa Sanderson ^c   Nazir, Niaman ^c   Benowitz, Neal L ^d,e   Yu, Lisa ^d   Yturralde, Olivia ^d   Jacob, Peyton ^d   Choi, Won S ^c   Ahluwalia, Jasjit S ^a   Nollen, Nicole L ^c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VARENICLINE;

ABSTINENCE; ADULT; AMERICAN INDIAN; ARTICLE; CIGARETTE SMOKING; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; ETHNIC GROUP; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT COUNSELING; PILL; PILOT STUDY; PRIORITY JOURNAL; RECALL; SELF REPORT; SMOKING CESSATION; TANDEM MASS SPECTROMETRY; TOBACCO DEPENDENCE; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADULT; AFRICAN AMERICANS; ATTITUDE TO HEALTH; BENZAZEPINES; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NICOTINIC AGONISTS; PILOT PROJECTS; QUINOXALINES; SELF REPORT; SMOKING CESSATION; TOBACCO USE DISORDER; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84866360450     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntr333     Document Type: Article

References (48)

1. Ahluwalia, J. S., Harris, K. J., Catley, D., Okuyemi, K. S., & Mayo, M. S. (2002). Sustained-release bupropion for smoking cessation in African Americans. Journal of the American Medical Association, 288,468-474. doi:10.1001/jama.288.4.468
2. Ahluwalia, J. S., Okuyemi, K., Nollen, N., Choi, W. S., Kaur, H., Pulvers, K., et al. (2006). The effects of nicotine gum and counseling among African American light smokers: A 2 × 2 factorial design . Addiction, 101,883-891. doi:10.1111/j.1360-0443. 2006.01461.x
3. Amico, K.R., Fisher, W.A., Cornman, D.H., Shuper, P.A., Redding, C.G., Konkle-Parker, D.J., et al. (2006). Visual analog scale of ART adherence: Association with 3-day self-report and adherence barriers. Journal of Acquired Immune Deficiency Syndromes, 42, 455-459. doi:10.1097/01.qai.0000225020.73760.c2
4. Baker, T. B., Piper, M. E., McCarthy, D. E., Bolt, D. M., Smith, Su-Young, K., et al. (2007). Time to first cigarette in the morning as an index of ability to quit smoking: Implications for nicotine dependence. Nicotine & Tobacco Research, 9 (Suppl. 4), S555-S570. doi: 10.1080/14622200701673480
5. Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Chesney, M., & Moss, A. (2001). Comparing objective measures of adherence to HIV antiretroviral therapy: Electronic medication monitors and unannounced pill counts. AIDS and Behavior,5, 275-281. doi:http://dx.doi.org/10.1023/A:1011396711486
6. Bosworth, H. B. (2006). Medication treatment adherence. In H. B. Bosworth, E. Z. Oddone, & M. Weinberger (Eds.), Patient treatment adherence: Concepts, interventions, and measurement (pp. 147-194), New York, NY: Routledge.
7. Breslau, N., & Johnson, E. O. (2000). Predicting smoking cessation and major depression in nicotine-dependent smokers. American Journal of Public Health, 90, 1122-1127. doi:10.2105/AJPH.90.7.1122
8. California Department of Health and Human Services, Tobacco Control Section. (2002). California tobacco survey: 1999. La Jolla, CA: Cancer Prevention and Control Unit.
9. Catz, S. L., Jack, L. M., McClure, J. B., Javitz, H. S., Deprey, M., Zbikowski, S. M., et al. (2011). Adherence to varenicline in the COMPASS smoking cessation intervention trial. Nicotine & Tobacco Research, 1, 361-368. doi: 10.1093/ntr/ntr003
10. Centers for Disease Control and Prevention. (2008). Smoking-attributable mortality, years of potential life lost, and productivity losses-2000-2004. Morbidity and Mortality Weekly Report, 57, 1226-1228. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5745a3.htm.
11. Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient care committee & adherence working group of the outcomes committee of the adult AIDS clinical trials group (AACTG). AIDS Care, 12, 255-266. doi:10.1080/09540120050042891
12. Cox, L. S., Nollen, N. L., Mayo, M. S., Choi, W. S., Faseru, B., Benowitz, N. L., et al. (2012). Bupropion for smoking cessation in African American light smokers: A randomized controlled trial. Journal of the National Cancer Institute, 104, 1-9. doi: 10.1093/jnci/djr513
13. Eisenberg, M. J., Filion, K. B., Yavin, D., Belisle, P., Mottillo, S., Joseph, L., et al. (2008). Pharmacotherapies for smoking cessation: A meta-analysis of randomized controlled trials. Canadian Medical Association Journal, 179, 135-144. doi:10.1503/cmaj.070256
14. Fagan, P., Moolchan, E. T., Lawrence, D., Fernander, A., & Ponder, P. K. (2007). Identifying health disparities across the tobacco continuum. Addiction, 102 (Suppl. 2), 5-29. doi:10.1111/j.1360-0443.2007.01952.x
15. Faessel, H. M., Smith, B. J., Gibbs, M. A., Gobey, J. S., Clark, D. J., & Burstein, A. H. (2006). Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers. Journal of Clinical Pharmacology, 46, 991-998. doi:10.1177/0091270006290669
16. Fiore, M. C., Jaén, C. R., Baker, T. B., Bailey, W. C., Benowitz, N. L., Curry, S. J., et al. (2008). Treating tobacco use and dependence: 2008 update. Clinical practice guideline. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service.
17. Fish, L. J., Peterson, B. L., Namenek Brouwer, R. J., Lyna, P., Oncken, C. A., Swamy, G. K., et al. (2009). Adherence to nicotine replacement therapy among pregnant smokers. Nicotine & Tobacco Research, 11, 514-518. doi: 10.1093/ntr/ntp032
18. Fisher, J. D., Fisher, W. A., Amico, K. R., & Harman, J. J. (2006). An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychology, 25, 462-473. doi:10.1037/0278-6133.25.4.462
19. Fu, S. S., Burgess, D. J., Hatsukami, D. K., Noorbaloochi, S., Clothier, B. A., Nugent, S., et al. (2008). Race and nicotine replacement treatment outcomes among low-income smokers. American Journal of Preventive Medicine, 35 (Suppl. 6), S442-S448. doi:10.1016/j.amepre.2008.09.009
20. Garrison, G. D., & Dugan, S. E. (2009). Varenicline: A first-line treatment option for smoking cessation. Clinical Therapeutics, 31, 463-491. doi:10.1016/j.clinthera.2009.03.021
21. Giordano, T. P., Guzman, D., Clark, R., Charlebois, E. D., & Bangsberg, D. R. (2004). Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clinical Trials, 5, 74-79. doi:10.1310/JFXH-G3X2-EYM6-D6UG
22. Haiman, C. A., Stram, D. O., Wilkens, L. R., Pike, M. C., Kolonel, L. N., Henderson, B. E., et al. (2006). Ethnic and racial differences in the smoking-related risk of lung cancer. New England Journal of Medicine, 354, 333-342. doi:10.1056/NEJMoa33250
23. Harris, R., Zang, E., Anderson, J., & Wynder, E. (1993). Race and sex differences in lung cancer risk associated with cigarette smoking. International Journal of Epidemiology, 22, 592-599. doi:10.1093/ije/22.4.592
24. Haynes, R. B., Ackloo, E., Sahota, N., McDonald, H. P., & Yao, X. (2008). Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews, (2), CD000011. doi:10.1002/14651858.CD000011.pub3
25. Hays, J. T., Leischow, S. J., Lawrence, D., & Lee, T. C. (2010). Adherence to treatment for tobacco dependence: Association with smoking abstinence and predictors of adherence. Nicotine & Tobacco Research, 12, 574-581. doi:10.1093/ntr/ntq047
26. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerström , K. O. (1991). The Fagerström test for nicotine dependence: A revision of the Fagerström tolerance questionnaire. British Journal of Addiction, 86, 1119-1127. doi:10.1111/j.1360-0443.1991.tb01879.x
27. Jimenez-Ruiz, C., Berlin, I., & Hering, T. (2009). Varenicline: A novel pharmacotherapy for smoking cessation. Drugs, 69, 1319-1338. doi:10.2165/00003495-200969100-00003
28. Kalichman, S. C., Amaral, C. M., Cherry, C., Flanagan, J., Pope, H., Eaton, L., et al. (2008). Monitoring medication adherence by unannounced pill counts conducted by telephone: Reliability and criterion-related validity. HIV Clinical Trials, 9, 298-308. doi: 10.1310/hct0905-298
29. Kalichman, S. C., Amaral, C. M., Stearns, H., White, D., Flanagan, J., Pope, H., et al. (2007). Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone . Journal of General Internal Medicine, 22, 1003-1006. doi:10.1007/s11606-007-0171-y
30. Killen, J. D., Fortmann, S. P., Murphy, G. M., Hayward, C., Arredondo, C., Cromp, D., et al. (2006). Extended treatment with bupropion SR for cigarette smoking cessation. Journal of Consulting and Clinical Psychology, 74, 286-294. doi:10.1037/0022-006X.74.2.286
31. Killen, J. D., Robinson, T. N., Ammerman, S., Hayward, C., Rogers, J., Stone, C., et al. (2004). Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers. Journal of Consulting and Clinical Psychology, 72 ,729-735. doi: 10.1037/0022-006X.72.4.729
32. Leischow, S. J., Ranger-Moore, J., Muramoto, M. L., & Matthews, E. (2004). Effectiveness of the nicotine inhaler for smoking cessation in an OTC setting. American Journal of Health Behavior, 28, 291-301. doi:10.5993/AJHB.28.4.1
33. Lu, M., Safren, S. A., Skolnik, P. R., Rogers, W. H., Coady, W., Hardy, H., et al. (2008). Optimal recall period and response task for self-reported HIV medication adherence. AIDS and behavior, 12, 86-94. doi:10.1007/s10461-007-9261-4
34. McDonald, H. P., Garg, A. X., & Haynes, R. B. (2002). Interventions to enhance patient adherence to medication prescriptions: Scientifi c review. Journal of the American Medical Association, 288, 2868-2879. doi:10.1001/jama.288.22.2868
35. Mooney, M. E., Sayre, S. L., Hokanson, P. S., Stotts, A. L., & Schmitz, J. M. (2007). Adding MEMS feedback to behavioral smoking cessation therapy increases compliance with bupropion: A replication and extension study. Addictive Behaviors, 32, 875-880. doi:10.1016/j.addbeh.2006.06.022
36. Nollen, N. L., Cox, L. S., Nazir, N., Ellerbeck, E. F., Owen, A., Pankey, S., et al. (2011). A pilot clinical trial of varenicline for smoking cessation in Black smokers. Nicotine & Tobacco Research, 13, 868-873. doi:10.1093/ntr.ntr063
37. Petersen, M. L., Wang, Y., van der Laan, M. J., Guzman, D., Riley, E., & Bangsberg, D. R. (2007). Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: A marginal structural model analysis. Clinical Infectious Diseases, 45, 908-915. doi: 10.1086/521250
38. Pleis, J. R., Ward , B. W., & Lucas, J. W. (2010). Summary health statistics for U.S. adults: National health interview survey, 2009. Vital Health Statistics, 10 , 1-259. Retrieved from http ://www. cdc. gov/nchs/data/series/sr_10/sr10_249. pdf
39. Ravva, P., Gastonguay, M. R., Tensfeldt, T. G., & Faessel, H. M. (2009). Population pharmacokinetic analysis of varenicline in adult smokers. British Journal of Clinical Pharmacology, 68, 669-681. doi:10.1111/j.1365-2125.2009.03520.x
40. Schmitz, J. M., Sayre, S. L., Stotts, A. L., Rothfleisch, J., & Mooney, M. E. (2005). Medication compliance during a smoking cessation clinical trial: A brief intervention using MEMS feedback. Journal of Behavioral Medicine, 28, 139-147. doi:10.1007/s10865-005-3663-4
41. Shiffman, S. (2007). Use of more nicotine lozenges leads to better success in quitting smoking. Addiction, 102, 809-814. doi:10.111/j.1360-0443.2007.01791.x
42. Shiffman, S., Sweeney, C. T., Ferguson, S. G., Sembower, M. A., & Gitchell, J. G. (2008). Relationship between adherence to daily nicotine patch use and treatment efficacy: Secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers. Clinical Therapeutics, 30, 1852-1858. doi:10.1016/j.clinthera.2008.09.016
43. Toll, B. A., McKee, S. A., Martin, D. J., Jatlow, P., & O'Malley, S. S. (2007). Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit. Nicotine & Tobacco Research, 9, 597-605. doi:777521519 [pii] 10.1080/14622200701239662
44. van Onzenoort, H. A. W., Verberk, W. J., Kessels, A. G. H., Kroon, A. A., Neef, C., van der Kuy, P. H., et al. (2009). Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild-to-moderate hypertension. American Journal of Hypertension, 23, 149-154. doi:10.1038/ajh.2009.207
45. Vermeire, E., Hearnshaw, H., Van Royen, P., & Denekens, J. (2001). Patient adherence to treatment: Three decades of research. A comprehensive review. Journal of Clinical Pharmacy and Therapeutics, 26, 331-342. doi:10.1046/j.1365-2710.2001.00363.x
46. Walsh, J. C., Mandalia, S., & Gazzard, B. G. (2002). Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS (London, England), 16, 269-277. doi:10.1097/00002030-200201250-00017
47. Webb, M. S. (2008). Treating tobacco dependence among African Americans: A meta-analytic review. Health Psychology, 27 (Suppl.), S271-S282. doi:10.1037/0278-6133.27.3(Suppl.).S271
48. Zweig, M. H., & Campbell, G. (1993). Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clinical Chemistry, 39, 561-577.